Dayang Chem (Hangzhou) Co., Ltd.
China
Product Name: 1-(4-Amino-6-bromo-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine hyd rochloride
Price: $Inquiry/100g $Inquiry/1kg $Inquiry/100kg $Inquiry/1000kg
Purity: 98.0%
Stocking Period: Inquiry
Contact: Ms Wang

111218-73-6

111218-73-6 structure

111218-73-6 structure

Name: 1-(4-Amino-6-bromo-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine hyd rochloride
Chemical Name: [4-(4-amino-6-bromoquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone,hydrochloride
CAS Number: 111218-73-6
Molecular Formula: C₁₇H₁₇BrClN₅O₂
Molecular Weight: 438.70600
Create Date: 2016-03-20 11:54:54
Modify Date: 2024-01-10 10:33:28

Name	[4-(4-amino-6-bromoquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone,hydrochloride

Boiling Point	642.1ºC at 760mmHg
Molecular Formula	C₁₇H₁₇BrClN₅O₂
Molecular Weight	438.70600
Flash Point	342.1ºC
Exact Mass	437.02500
PSA	89.22000
LogP	3.26490
Vapour Pressure	2.22E-16mmHg at 25°C

CHEMICAL IDENTIFICATION

RTECS NUMBER :: TK8030300

CHEMICAL NAME :: Piperazine, 1-(4-amino-6-bromo-2-quinazolinyl)-4-(2-furanylcarbon yl)-, monohydrochloride

CAS REGISTRY NUMBER :: 111218-73-6

LAST UPDATED :: 199712

DATA ITEMS CITED :: 1

MOLECULAR FORMULA :: C17-H16-Br-N5-O2.Cl-H

MOLECULAR WEIGHT :: 438.75

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :: LD50 - Lethal dose, 50 percent kill

ROUTE OF EXPOSURE :: Oral

SPECIES OBSERVED :: Rodent - mouse

DOSE/DURATION :: >400 mg/kg

TOXIC EFFECTS :: Details of toxic effects not reported other than lethal dose value

REFERENCE :: PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- Volume(issue)/page/year: 21,478,1987

111218-89-4 structure

111218-89-4

40172-95-0 structure

40172-95-0

~98%

111218-73-6 structure

111218-73-6

Literature: Volzhina, O. N.; Azimov, V. A.; Medvedev, B. A.; Kazakov, A. A.; Zhikhareva, G. P.; et al. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 7 p. 478 - 483 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 7 p. 802 - 807

88145-89-5 structure

88145-89-5

~%

111218-73-6 structure

111218-73-6

Literature: Volzhina, O. N.; Azimov, V. A.; Medvedev, B. A.; Kazakov, A. A.; Zhikhareva, G. P.; et al. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 7 p. 478 - 483 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 7 p. 802 - 807

102393-82-8 structure

102393-82-8

~%

111218-73-6 structure

111218-73-6

Literature: Volzhina, O. N.; Azimov, V. A.; Medvedev, B. A.; Kazakov, A. A.; Zhikhareva, G. P.; et al. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 7 p. 478 - 483 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 7 p. 802 - 807

5794-88-7 structure

5794-88-7

~%

111218-73-6 structure

111218-73-6

Literature: Volzhina, O. N.; Azimov, V. A.; Medvedev, B. A.; Kazakov, A. A.; Zhikhareva, G. P.; et al. Pharmaceutical Chemistry Journal, 1987 , vol. 21, # 7 p. 478 - 483 Khimiko-Farmatsevticheskii Zhurnal, 1987 , vol. 21, # 7 p. 802 - 807